FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3114401019> ?p ?o ?g. }

• W3114401019 endingPage "309" @default.
• W3114401019 startingPage "302" @default.
• W3114401019 abstract "Aims Previous uncontrolled studies suggested a possible benefit of intravenous immunoglobulin (IVIg) in parvovirus B19 (B19V)‐related dilated cardiomyopathy (DCM). This randomized, double‐blind, placebo‐controlled, single‐centre trial investigated the benefits of IVIg beyond conventional therapy in idiopathic chronic DCM patients with B19V persistence. Methods and results Fifty patients (39 men; mean age 54 ± 11 years) with idiopathic chronic (>6 months) DCM on optimal medical therapy, left ventricular ejection fraction (LVEF) <45%, and endomyocardial biopsy (EMB) B19V load of >200 copies/µg DNA were blindly randomized to either IVIg ( n = 26, 2 g/kg over 4 days) or placebo ( n = 24). The primary outcome was change in LVEF at 6 months after randomization. Secondary outcomes were change in functional capacity assessed by 6‐min walk test (6MWT), quality of life [Minnesota Living with Heart Failure Questionnaire (MLHFQ)], left ventricular end‐diastolic volume (LVEDV), and EMB B19V load at 6 months after randomization. LVEF significantly improved in both IVIg and placebo groups (absolute mean increase 5 ± 9%, P = 0.011 and 6 ± 10%, P = 0.008, respectively), without a significant difference between groups ( P = 0.609). Additionally, change in 6MWT [median (interquartile range) IVIg 36 (13;82) vs. placebo 32 (5;80) m; P = 0.573], MLHFQ [IVIg 0 (−7;5) vs. placebo −2 (−6;6), P = 0.904] and LVEDV (IVIg −16 ± 49 mL/m 2 vs. placebo −29 ± 40 mL/m 2 ; P = 0.334) did not significantly differ between groups. Moreover, despite increased circulating B19V antibodies upon IVIg administration, reduction in cardiac B19V did not significantly differ between groups. Conclusion Intravenous immunoglobulin therapy does not significantly improve cardiac systolic function or functional capacity beyond standard medical therapy in patients with idiopathic chronic DCM and cardiac B19V persistence. Clinical Trial Registration: ClinicalTrials.gov ID NCT00892112." @default.
• W3114401019 created "2021-01-05" @default.
• W3114401019 creator A5000422141 @default.
• W3114401019 creator A5001781828 @default.
• W3114401019 creator A5001853031 @default.
• W3114401019 creator A5005113058 @default.
• W3114401019 creator A5018488441 @default.
• W3114401019 creator A5018923408 @default.
• W3114401019 creator A5029613985 @default.
• W3114401019 creator A5057731621 @default.
• W3114401019 creator A5057864298 @default.
• W3114401019 creator A5061900184 @default.
• W3114401019 creator A5065724319 @default.
• W3114401019 creator A5066723872 @default.
• W3114401019 creator A5067774235 @default.
• W3114401019 creator A5078850892 @default.
• W3114401019 creator A5086106258 @default.
• W3114401019 date "2021-01-07" @default.
• W3114401019 modified "2023-10-16" @default.
• W3114401019 title "Intravenous immunoglobulin therapy in adult patients with idiopathic chronic cardiomyopathy and cardiac parvovirus <scp>B19</scp> persistence: a prospective, double‐blind, randomized, placebo‐controlled clinical trial" @default.
• W3114401019 cites W1519683225 @default.
• W3114401019 cites W163567332 @default.
• W3114401019 cites W1951724000 @default.
• W3114401019 cites W1965881193 @default.
• W3114401019 cites W1967408616 @default.
• W3114401019 cites W1975756380 @default.
• W3114401019 cites W1982824341 @default.
• W3114401019 cites W1983419841 @default.
• W3114401019 cites W1984047238 @default.
• W3114401019 cites W1986817239 @default.
• W3114401019 cites W1996110848 @default.
• W3114401019 cites W2000366267 @default.
• W3114401019 cites W2002130113 @default.
• W3114401019 cites W2015708271 @default.
• W3114401019 cites W2048711081 @default.
• W3114401019 cites W2052975279 @default.
• W3114401019 cites W2080629518 @default.
• W3114401019 cites W2094163523 @default.
• W3114401019 cites W2105261767 @default.
• W3114401019 cites W2136260361 @default.
• W3114401019 cites W2136732030 @default.
• W3114401019 cites W2137493259 @default.
• W3114401019 cites W2138589350 @default.
• W3114401019 cites W2139998668 @default.
• W3114401019 cites W2140921081 @default.
• W3114401019 cites W2151448987 @default.
• W3114401019 cites W2163101375 @default.
• W3114401019 cites W2169785058 @default.
• W3114401019 cites W2257153004 @default.
• W3114401019 cites W2538222654 @default.
• W3114401019 cites W2563363914 @default.
• W3114401019 cites W2619692685 @default.
• W3114401019 cites W2745231250 @default.
• W3114401019 cites W2780741330 @default.
• W3114401019 cites W2886546649 @default.
• W3114401019 cites W2887314940 @default.
• W3114401019 cites W2901071128 @default.
• W3114401019 cites W2939322499 @default.
• W3114401019 cites W2947315201 @default.
• W3114401019 cites W2972235069 @default.
• W3114401019 doi "https://doi.org/10.1002/ejhf.2082" @default.
• W3114401019 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/8048650" @default.
• W3114401019 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/33347677" @default.
• W3114401019 hasPublicationYear "2021" @default.
• W3114401019 type Work @default.
• W3114401019 sameAs 3114401019 @default.
• W3114401019 citedByCount "23" @default.
• W3114401019 countsByYear W31144010192021 @default.
• W3114401019 countsByYear W31144010192022 @default.
• W3114401019 countsByYear W31144010192023 @default.
• W3114401019 crossrefType "journal-article" @default.
• W3114401019 hasAuthorship W3114401019A5000422141 @default.
• W3114401019 hasAuthorship W3114401019A5001781828 @default.
• W3114401019 hasAuthorship W3114401019A5001853031 @default.
• W3114401019 hasAuthorship W3114401019A5005113058 @default.
• W3114401019 hasAuthorship W3114401019A5018488441 @default.
• W3114401019 hasAuthorship W3114401019A5018923408 @default.
• W3114401019 hasAuthorship W3114401019A5029613985 @default.
• W3114401019 hasAuthorship W3114401019A5057731621 @default.
• W3114401019 hasAuthorship W3114401019A5057864298 @default.
• W3114401019 hasAuthorship W3114401019A5061900184 @default.
• W3114401019 hasAuthorship W3114401019A5065724319 @default.
• W3114401019 hasAuthorship W3114401019A5066723872 @default.
• W3114401019 hasAuthorship W3114401019A5067774235 @default.
• W3114401019 hasAuthorship W3114401019A5078850892 @default.
• W3114401019 hasAuthorship W3114401019A5086106258 @default.
• W3114401019 hasBestOaLocation W31144010191 @default.
• W3114401019 hasConcept C119060515 @default.
• W3114401019 hasConcept C126322002 @default.
• W3114401019 hasConcept C142724271 @default.
• W3114401019 hasConcept C164705383 @default.
• W3114401019 hasConcept C168563851 @default.
• W3114401019 hasConcept C202061045 @default.
• W3114401019 hasConcept C203014093 @default.
• W3114401019 hasConcept C204243189 @default.
• W3114401019 hasConcept C204787440 @default.
• W3114401019 hasConcept C2522874641 @default.
• W3114401019 hasConcept C27081682 @default.

• next